avcf.hkvca.com.hk Open in urlscan Pro
198.57.242.191  Public Scan

Form analysis
0 forms found in the DOM

Text Content

About HKVCA  |  Other HKVCA events  |  Contact us


Navigation
 * Home
 * Past Events
   * AVCF 2022
   * AVCF 2021
   * AVCF 2020
   * AVCF 2019
   * VENTURE 2018
   * HKVCF 2017
   * HKVCF 2016
   * HKVCF 2015
   * HKVCF 2014
 * Program
 * Register Now

 * Home
 * Past Events
   
   * AVCF 2022
   * AVCF 2021
   * AVCF 2020
   * AVCF 2019
   * VENTURE 2018
   * HKVCF 2017
   * HKVCF 2016
   * HKVCF 2015
   * HKVCF 2014
 * Program
 * Register Now


PROGRAM

  10:00 am – 10:05 am

Opening Remarks by Conference Co-chair

Melissa Guzy, Managing Partner, Arbor Ventures

  10:05 am – 10:25 am

Fireside Chat

Wendy Zhu, Partner, Managing Director & Global Head, AlpInvest Partners

Melissa Guzy, Managing Partner, Arbor Ventures

  10:25 am – 11:05 am

Panel Discussion: SEA

 * What makes SEA region attractive for large global institutional investors on
   a risk adjusted basis?
 * What are the differentiated investment opportunities for investors that are
   not available elsewhere in the Asia region?
 * What is driving the growth of digital and venture ecosystem in SEA and how is
   that translating to investable opportunities?
 * How does one successfully invest in SEA given the significant diversity in
   the region?
 * Which regions/ countries provide the most attractive investment
   opportunities?
 * Do the demographic and geopolitical tailwinds translate into an increase in
   investable opportunity for PE in the region
 * Has SEA delivered to its investment promise till date and what is the outlook
   going forward?

Moderator

Yan Yang, Managing Director & Head of APAC Investment , BlackRock Private Equity
Partners


Panelists

Praneet Garg, Managing Director, Asia Alternatives

Matthias Knobloch, Founding Partner and CEO, Betatron Venture Group

Yinglan Tan, Founding Managing Partner, Insignia Ventures Partners

Amit Anand, Founding Partner, Jungle Ventures

  11:05 am – 11:45 am

Panel Discussion: Biotech

Biotech can be viewed as a tale of two cities.  While Asian capital markets for
biotech companies have seen their fair share of challenges, US markets have
fared relatively well.  Nuclear medicine for cancer treatment is now being
embraced globally, including in China, and we have witnessed acquisitions in the
billions in the US.  Universities in Hong Kong continue to be a hotbed for
biotech innovation, and entrepreneurs from both Hong Kong and China are
targeting the broader markets in the Greater Bay Area and Asia.  Our four
distinguished panelists - two entrepreneurs, a renowned professor and an active
investor – will discuss their views on the market and future disruptions in
biotech.

Moderator

Catherine Leung, Co-Founder and Partner, MizMaa Ventures

Panelists

Dr. Eddy Wu, Founder, Chairman and CEO, Arctic Vision

Prof. Ying Chau, HKUST, Co-founder of Pleryon Therapeutics and Allegrow Biotech

Jane Wu, Chief Investment Officer, Springhill Fund

Clement Tam, CEO, ZERO Biotech

  11:45 am – 12:30 pm

Panel Discussion: China

Moderator

Tommy Yip, Managing Partner, Unicorn Capital Partners

Panelists

Ray Hu, Managing Partner, Blue Lake Capital

Eric Yang, Founding Partner, Glory Ventures

Yuan Liu, Partner, Zhenfund

  12:30 pm - 1:30 pm

Networking Lunch

@ Sea View Concourse,
Level 3, Core E, Cyberport 3

  1:30 pm - 2:10 pm

Panel Discussion: Hong Kong

This panel discussion will provide valuable insights into the current VC/PE
landscape in Hong Kong, examining market sentiments, comparisons to other
regions, and the evolving focus on sectors like AI, semiconductors, and biotech.
Esteemed panelists will also share their perspectives on Hong Kong’s government
policies and incentives aimed at driving I&T development, including funding and
research institute initiatives. Additionally, the discussion will explore what
calibers and success stories make ventures attractive for investment in Hong
Kong, offering practical advice for entrepreneurs seeking to catch the attention
of investors in this dynamic market.

Moderator

Andy Wong, Head of Innovation and Technology, Invest Hong Kong

Panelists

Eric Chan, Chief Public Mission Officer, Cyberport Hong Kong

Raymond Wong, Head of Investment, HKSTP

Philea Chim, Senior Vice President, QBN Capital

Edith Yeung, General Partner, Race Capital

  2:10 pm - 2:50 pm

Panel Discussion: Fintech

Moderator

Abhishek Kumar, Partner, Head of Insurance, KPMG Hong Kong


Panelists

Kenny Man, Managing Partner, 01Fintech

Julia Hu, Vice President, C Capital

Jonathan Larsen, Chief Innovation Officer, Ping An Group; Chairman and CEO, Ping
An Global Voyager Fund

  2:50 pm - 3:30 pm

Panel Discussion: LP

Moderator

Pamela Fung, Managing Director, Morgan Stanley Investment Management Private
Equity Solutions

Panelists

Brooke Zhou, Partner, LGT Capital Partners

Tommy Yip, Managing Partner, Unicorn Capital Partners

  3:30 pm - 3:35 pm

Closing Remarks by Conference Co-chair

Tommy Yip, Managing Partner, Unicorn Capital Partners

Platinum Sponsor:

Co-hosts:

.

Silver Sponsor:

Luncheon Sponsor:

Venture Sponsor:


SPEAKERS' BIO

KENNY MAN

Managing Partner,
01Fintech

Kenny has been a pioneer in Asia-Pacific technology investments for over 15
years.

Prior to founding 01Fintech, a fintech focused growth stage fund in Asia, he was
Ant Group’s Head of International Investment from 2015 to 2022. During his
tenure at Ant, his team invested about USD 5bn in over 30 Fintech related deals
and was managing approximately USD 20bn in AUM at the time of his departure;
track record included 9 Unicorns, 6 exist and 4 IPOs.

He also established and headed Alibaba’s Overseas Investment & Acquisition team
in 2009 and was previously at McKinsey & Co.

Kenny has invested and helped grow, as an advisor and Board member, some of
Asia’s largest fintech companies.

<Program>

WENDY ZHU

Partner, Managing Director
& Global Head,
AlpInvest Partners
Wendy is a Partner, Managing Director and Global Head of AlpInvest Partners’
Primary Fund Investments team. She is also responsible for the Secondary and
Portfolio Finance team in the Asia Pacific region and a member of the Operating
Committee. She joined AlpInvest Partners in 2007 from Macquarie Funds
Management, where she was Senior Vice President of Asia-Pacific regional private
equity fund investments and co-investments. Previously, Wendy was a Director
with Deutsche Bank Asset Management and an Associate Director at MetLife. Wendy
received a BS in Business Administration and an MS in Accounting from the
University of Southern California. She represents AlpInvest Partners on various
Advisory Boards.
<Program>

MELISSA GUZY

Managing Partner,
Arbor Ventures

Melissa C. Guzy serves as the Founder and Managing Partner at Arbor Ventures.
Prior to establishing Arbor Ventures, Melissa held the role of Managing Partner
and was a pivotal member of the Investment Committee at VantagePoint Capital
Partners. Her current portfolio of board positions encompasses InCountry, Tabby,
Ready, Nomi Health, and TrueAccord. Notably, Melissa played the role of investor
board member for Paidy, a company that was subsequently acquired by Paypal for
an impressive $2.88 billion. Beyond her corporate involvements, Melissa also
holds a position on the Board of Trustees at The Jackson Laboratory, an
institution committed to uncovering precise genomic solutions for diseases and
fostering global collaboration within the biomedical community to enhance human
health.

Melissa’s academic journey led her to Wellesley College, and she further
advanced her education by obtaining a Master of Science in Finance from the
University of Florida. Her scholarly contributions include the paper “Venture
Capital Returns and Public Market Performance.” She holds a prominent role as
the Co-Chair of the Venture Committee within the Hong Kong Venture Capital and
Private Equity Association (HKVCA), and she also serves on the Board of
Directors of the HKVCA. Notably, she was previously a member of the Hong Kong
SFC on Innovation. Melissa’s expertise extends to academia, where she served as
a guest lecturer on Venture Capital Industry at prestigious institutions such as
the University of Florida, Hong Kong University, Chinese University of Hong
Kong, and the Hong Kong University of Science and Technology.

Furthermore, Melissa is a distinguished Hopkins Fellow and an alumna of the
Women’s Leadership Program at Harvard University. Her accomplishments have
garnered recognition, including being listed as a Top 100 Influencer in Fintech
by NxtBnk, earning the designation of an AlwaysOn Fintech Power Player, and
being acknowledged as one of the Top 13 Women in Asia who are Tech Influencers.

<Program>

DR. EDDY WU

Founder, Chairman and CEO,
Arctic Vision

Dr. Wu is a committed and proactive professional with a highly successful local
and global background in basic science research, clinical development, medical
affairs, health economics and commercialization throughout the whole development
circle of drugs & devices. Before he founded Arctic Vision, he was the Head of
Terns China Biotechnology where he was responsible for directing and overseeing
all aspects of R&D activities as well as general management responsibilities.
Before Terns, he was the Executive Director at Allergan China where he was
responsible for Allergan's overall R&D, clinical, medical and portfolio strategy
for China. Previous to his work at Allergan, he was based in Novartis Basel
headquarter, Hong Kong, and Taiwan and held various positions with increasing
responsibilities and gained in first-hand global experience.

Besides his extensive experience in the healthcare industry, Dr. Wu also owns
multiple social titles such as the Senior Fellow of Social Enterprise Research
Academy, the Outstanding Young Entrepreneur of Guangdong-HK-Macao Bay Area, and
Economic Innovator in the New Era.

Dr. Wu graduated with a bachelor's degree in Biochemistry from the Hong Kong
University of Science and Technology (HKUST), where he also obtained his Ph.D.
in Biochemistry. He also holds 22 patents and 35 academic publications.

<Program>

PRANEET GARG

Managing Director,
Asia Alternatives
Praneet Garg is a Managing Director in Asia Alternatives’ Hong Kong office. Mr.
Garg co-leads Asia Alternatives’ investments in India, Australia and South East
Asia, and is primarily responsible for deal sourcing, due diligence, deal
execution and portfolio management of private equity fund investments and direct
co-investments in these geographies. Mr. Garg also leads Asia Alternatives'
market research function. Prior to joining Asia Alternatives, Mr. Garg had over
five years of consulting and research experience with the Private Equity
Practice at McKinsey & Company in the Delhi and London offices. He worked with
McKinsey Private Equity client teams on issues of Private Equity strategy,
organization, performance and due diligence. He also led the Private Equity
research team and authored several market research pieces on Asia Private Equity
and other related topics. Mr. Garg holds a Bachelor of Commerce degree and an
MBA from Mumbai University. Mr. Garg is fluent in Hindi, Punjabi and English.
Mr. Garg currently serves on the Advisory Boards of several of Asia
Alternatives' Pan Asian, Indian, Australian and Indonesian funds. Asia
Alternatives Management, founded in 2006, is a solution platform dedicated to
helping institutional investors make investments in private equity across Asia.
The firm's research, investment and client service infrastructure is solely
dedicated to Asian private equity fund investments from offices in Hong Kong,
Beijing, Shanghai and San Francisco. Asia Alternatives diversifies its
investment program by targeting private equity fund managers in Asia.
<Program>

MATTHIAS KNOBLOCH

Founding Partner and CEO,
Betatron Venture Group
Matthias is the Founding Partner and CEO of Betatron Venture Group (BVG).
Matthias has two decades of buyside and sell-side experience, fifteen years in
Hong Kong and five in London. At BVG, Matthias and his team have invested in
more than fifty portfolio companies and delivered three exits. Betatron is now
deploying out of its fourth fund, focused on B-2-B tech companies headquartered
in Hong Kong and Singapore. Prior to founding BVG, Matthias was Managing
Director and Head of Debt Syndicate Asia-Pacific at HSBC. Matthias holds a
Master in Mathematical Finance degree from the University of Toronto as well as
an MBA.
<Program>

YAN YANG

Managing Director &
Head of APAC Investment,
BlackRock Private Equity Partners

Yan Yang, M.D., CFA, CAIA, Managing Director, is Head of APAC Investment of
BlackRock Private Equity Partners (PEP). Mr. Yang is a member of PEP Global
Executive Committee, PEP Global Investment Committee and Investment Committee of
BlackRock APAC Private Credit Fund. He also leads account coverage for several
major institutional clients of PEP in the region. With a background in medicine,
Mr. Yang plays an important role in PEP's global healthcare investment strategy.

Prior to joining BlackRock in 2011, Mr. Yang had worked at China Investment
Corporation in Beijing where he was covering primary PE funds, direct
co-investments and secondary investments globally, with a focus on developed
markets. Prior to CIC, Mr. Yang worked at GE Asset Management and managed U.S.
private equity assets, both funds and co-investments, for the GE Pension Trust.
Mr. Yang started his career at GE Healthcare's information technology business.

Mr. Yang is a CFA charter holder and a Chartered Alternative Investment Analyst
(CAIA) member. He holds a MD degree in Clinical Medicine from the Peking Union
Medical College, and a MBA from the Robert Emmett McDonough School of Business
at the Georgetown University.

<Program>

RAY HU

Managing Partner,
Blue Lake Capital

Professional Experience:

2014/9 - present Founder and Managing Partner, Blue Lake Capital 2007/7 - 2014/6
Vice President, GGV Capital 2002/9 - 2007/6 Consultant, Boston Consulting Group

Ray Hu has over a decade of experience in venture capital investing. Ray’s keen
discernment of industry trends and business models has driven his current focus
on software and industrial digitalization. Ray is responsible for successful
investments in many well-known companies, including Momenta, Yiheda (SHE:
301029), Meicai, Cloud Helios, Zhenyun, Moka, Thinking Data, Trensor and
Itimotor. Prior to founding Blue Lake Capital, Ray worked at GGV Capital, where
he led investments in 21Vianet (Nasdaq: VNET), Qunar.com (Nasdaq: QUNR), MediaV
[acquired by Qihoo 360 (NYSE: QIHU) and Leo Group (SZ: 002131)], Grab (GRAB),
and Meilishuo.com. Before entering venture capital investing, he worked at the
Boston Consulting Group (BCG). Ray holds a bachelor’s and master’s degree in
Economics from Fudan University and an MBA Degree from the Kellogg School of
Management at Northwestern University.

<Program>

JULIA HU

Vice President,
C Capital
Vice President at C Capital. Graduated from University of Pennsylvania, and
previously with Manulife / John Hancock Bond Group in Boston, her investment
experience spans from US to Asia and from corporate bond to PE, VC, and Web 3
investment.
<Program>

ERIC CHAN

Chief Public Mission Officer,
Cyberport Hong Kong
Ir Eric Chan is the Chief Public Mission Officer of Cyberport. Ir Chan oversees
the public mission operation and the ecosystem of nurturing start-ups in Hong
Kong. He is an ICT veteran, a chartered engineer, and a Fellow of IET (UK).
Prior to joining Cyberport, Ir Chan held various senior positions in global ICT
companies. He has been active in public services, especially in education and
industrial training, and serves on a number of committees for the Government,
universities, professional bodies and charitable organisations. Ir Chan is
currently Chairman of ITAC (ICT Sector) and Chairman of Knowledge Management
Development Center.
<Program>

ERIC YANG,

Founding Partner,
Glory Ventures

Mr. Eric Yang, founding partner of Glory Ventures, a leading early stage
deep-tech VC, focusing on the field of new generation information technologies
and climate tech. Eric Yang formerly served as the Vice President at SMC Capital
and Senior Associate at Infinity Venture Capital, was responsible for investing
in emerging industries, has extensive experience working internationally in the
TMT industry and venture capital.

Eric held positions as a manager at SK Telecom in Seoul prior to becoming a
venture investor. Eric is an Shanghai Jiaotong University (SJTU)
entrepreneurship tutor and has a B.Sc. and M.Sc. in Electronic Engineering from
SJTU.

<Program>

PROF. YING CHAU

HKUST; Co-founder of Pleryon Therapeutics and Allegrow Biotech
Ying Chau (Ph.D. in Chemical Engineering, MIT) is Professor in the Department of
Chemical and Biological Engineering at the Hong Kong University of Science and
Technology (HKUST). She is an academic entrepreneur with 25+ years of experience
in the field of biomaterials and drug delivery. Her current interests include
the design and translation of drug delivery approaches and biomaterials for
ocular applications and immunotherapy. The technologies developed from her lab
are now being commercialized by start-up companies in Hong Kong and Shenzhen.
Pleryon Therapeutics is commercializing long-acting polymeric therapeutics for
chronic diseases affecting the aging population. Allegrow Biotech is developing
adaptable biomaterials and harnessing machine learning to accelerate the
development of next-generation cell therapy. Opharmic Technology is developing
an ultrasound platform for safe, effective and needless delivery of drugs.
Currently, she is serving on the board of directors of the Nano and Advanced
Materials Institute Limited (Hong Kong) and the editorial boards of Advanced
Drug Delivery Reviews (Elsevier). She is the Associate Editor of Drug Delivery
(Taylor & Francis) and Frontiers in Drug Delivery (Frontiers).  Professor Chau
is also deeply interested in education innovation and a strong advocate to
empower students for impact creation. She is the Founder and Director of Student
Innovation for Global Health Technology (SIGHT) at HKUST. She was named the
“Leading Woman in STEM” at the 2021 Annual Women of Influence (WOI) Conference &
Awards organized by the American Chamber of Commerce in Hong Kong (AmCham).
<Program>

RAYMOND WONG

Head of Investment,
Hong Kong Science and Technology Parks Corporation

Raymond Wong, Head of Investment, Hong Kong Science and Technology Parks
Corporation (HKSTP), manages the HKSTP Corporate Venture Fund and Business and
Investment Support departments.  He has 25 years of extensive financial services
experience in private equity investment, portfolio management, merger and
acquisition as well as strategic investment across multiple sectors in the Asia
Pacific region.  Prior to HKSTP, Raymond was a principal in HPEF Capital
Partners, previously known as HSBC Private Equity Asia, and participated in
three consecutive Asian funds for 16 years.  Prior to HSBC, Raymond held various
roles at ABN AMRO Bank in the proprietary capital investment, equity capital
markets and corporate finance divisions.  Previously, he was a software
developer at IBM Laboratory in Toronto, Canada.   Raymond is a member of the
Venture Committee, Hong Kong Venture Capital and Private Equity Association.

Raymond obtained a Bachelor of Applied Science in Engineering Science (Computer
Aided Design and Manufacturing) from University of Toronto and a Master of
Business Administration in Finance from Columbia Business School, New York.

<Program>


YINGLAN TAN

Founding Managing Partner,
Insignia Ventures Partners
Yinglan founded Insignia Ventures Partners in 2017. Insignia Ventures Partners
is an early-stage technology venture fund focusing on Southeast Asia and manages
more than US$350 million from sovereign wealth funds, foundations, university
endowments and renowned family offices. Insignia Ventures Partners is the
recipient of two back-to-back “VC Deal of Year” awards for Payfazz (2019) and
Carro (2018) from the Singapore Venture Capital and Private Equity Association
and its portfolio include many other technology leaders in Southeast Asia. He
also co-hosts the On Call with Insignia Ventures podcast, where he chats with
portfolio founders and regional investors. An author on venture capital,
startups and innovation, he recently published his fourth book, Navigating
ASEANnovation (World Scientific, 2020). He also serves on the International
Board of Stars – Leaders of the Next Generation, the Singapore Government’s Pro
Enterprise Panel and is a Board Member at Hwa Chong Institution.
<Program>

ANDY WONG

Head of Innovation and Technology,
Invest Hong Kong

Mr. Andy Wong is the Head of Innovation and Technology at Invest Hong Kong
(InvestHK), the government department responsible for attracting and
facilitating foreign direct investment into Hong Kong.  His key focused
technology segments include biotech, medical devices, healthcare, AI and
robotics, microelectronics, new materials, and green technologies.

Mr. Wong has wealth strategy consulting and business development experience in
high tech sector. Before joining InvestHK, Mr. Wong held various senior
positions at a global leading consulting firm and a global Fortune 500
technology company specialising in corporate strategy and business development.

Mr. Wong graduated from the University of Birmingham, the UK with First Class
Honor Degree in Electronic and Electrical Engineering, a Master Degree in
Commerce from the University of New South Wales, Australia and a Master of
Science in Real Estate from the University of Hong Kong.  Mr. Wong is a
Chartered Engineer (CEng) from The Institution of Engineering and Technology,
the UK; and is a Member of the Certified Practicing Accounting, (CPA) Australia
by training.

<Program>

AMIT ANAND

Founding Partner,
Jungle Ventures

Amit has spent 25 years in South Asia as an early pioneer and leader in the
development of the region's Venture Capital Industry. Amit was the Vice Chairman
of Business Angels Network of SouthEast Asia (BANSEA), which is Asia's oldest
and largest angel investment network. He helped scale the network both in terms
of its impact and reach where today it has supported the development of over
15000 Founders and made 400 investments in the region.

Amit has since shaped Jungle's investment approach and philosophy over the
years, and in turn overseen investments in some of Jungle's leading portfolio
companies such as Travelmob (exit to HomeAway), Zipdial (exit to Twitter),
TradeGecko (exit to Intuit), Pomelo Fashion, Reddoorz, Kredivo amongst other
stars. His involvement in these companies goes beyond investment and he has
actively led various efforts ranging from recruiting board members, recruiting
and mentoring key executives, to forming strategic partnerships and handcrafting
cross border scale up plans.

Previously, Amit held executive positions in sales and business development
roles at Progress Software ($1.6 Billion NASDAQ listed software giant), STT
Communications backed and Singapore based Elipva (acquired by a Hong Kong Listed
Company) and earlier at Tata Infotech Ltd, India (Acquired by TCS for ~$259m).
In 2006, Amit switched gears & began his journey as an entrepreneur when he
founded Ettamina Studios, a Singapore-India based animation studio with
ambitions to build a global company from Asia. A passion which later led him to
start Jungle Ventures and more recently invest in disruptive ideas such as
Livspace and Builder.AI where he continues to help them grow into global
category creators.

He is a Kauffman Fellow, one of the earliest from South East Asia and currently
also a member of Singapore Government's Advisory Council on the Ethical Use Of
Artificial Intelligence and Data. Amit holds a Bachelor’s degree with a major in
Computer Science.

<Program>

ANSON BAILEY

Head of Consumer & Retail, Asia Pacific,
KPMG China

Anson joined KPMG in Hong Kong in 1999 and is currently a Partner based in the
Hong Kong office heading up the Consumer & Retail Practice in the Asia Pacific
region. Today, he is part of the KPMG Global Consumer & Retail Leadership team.

Anson has been active in driving a number of thought leadership reports and
executive briefings for senior executives covering innovation and consumers in
China and across the Asia Pacific region. He has worked with many corporates to
understand the complex markets we live in and current levels of disruption being
seen with various thought leadership reports including Global Mobile Payments,
Consumers & Convergence, Mobilizing Innovation: The Changing Landscape of
Disruptive Technologies, The Rise of the Digital Multi-tasker, Be a Smarter
Start-up, MNCs in China, Made in China 2025, China’s Connected Consumers, Global
Connected Consumers, Connecting Hong Kong – Perspectives on our future as a
smart city, Connected Cities – insights across the ASPAC region, Retail
Recharged, The Future of Seamless Commerce in Asia Pacific and The Changing Face
of Commerce series.

Today, he works with a growing number of C-level executives as a trusted advisor
in looking at the customer and providing the best in client innovation whilst
acting as the Lead Partner for a number of strategic accounts in both the
consumer and tech arena across the Asia Pacific region.

He strongly believes in supporting local communities with various outreach
programs and nurturing the next generation of young leaders. Anson is a frequent
speaker at conferences and events around the globe and has completed his
Executive Masters in Innovation & Technology with the Poly University as well as
the MIT Executive Leadership & Innovation Program.

<Program>

ABHISHEK KUMAR

Partner, Head of Insurance,
KPMG Hong Kong
Abhishek leads KPMG insurance consulting practice in Hong Kong, and has global
experience in the insurance sector as an actuary and an insurance professional.
He has advised leading insurers across the globe in a range of topics relating
to regulatory changes, financial reporting, risk and capital management, finance
and operational transformation. Abhishek has worked with large global insurers
with particular focus on their strategy and execution of those strategies in
Asia Pacific. He regularly interacts with regulators in the ASPAC region, and
works with industry bodies on topics of customer conduct, regulatory and
accounting changes. Abhishek has spent significant years in Asia working in Hong
Kong, Singapore and India.
<Program>

BROOKE ZHOU

Partner,
LGT Capital Partners

Brooke Zhou is Partner of LGT Capital Partners, and leads LGT CP’s secondary
investment activities in Asia, as well as the firm’s overall China business.

Prior to joining LGT Capital Partners in 2010, Ms. Zhou was with CDH
Investments, a leading Chinese private equity manager, based in Beijing. Prior
to CDH Investments, Ms. Zhou spent her career at Bain & Company in Shanghai, as
well as Oracle Corporation in Redwood Shores, California.

Ms. Zhou earned an MBA from Harvard Business School and a Bachelor of Science
from Massachusetts Institute of Technology. Ms. Zhou grew up in Shanghai and is
fluent in Mandarin Chinese.

LGT Capital Partners is a leading institutional alternative asset and fund of
funds manager, currently managing over USD 100 billion AuM on a global basis and
over 600 private equity professionals worldwide. The firm is headquartered in
Pfäffikon, Switzerland (near Zurich) and has offices in Hong Kong, Beijing,
Tokyo, Sydney, New York, Dublin, London, Paris, Frankfurt, Vaduz and Dubai.

<Program>

CATHERINE LEUNG

Co-Founder and Partner,
MizMaa Ventures

Catherine K.C. Leung is Co-Founder and Partner of MizMaa Ventures.  She is
currently a board member of Orca.ai, Aurora Labs, ClearML, Syte, and HEXIGHT.
Previously, Catherine was a board member of Corephotonics which was sold to
Samsung and a board member of Vayavision sold to Leddartech.

Prior to MizMaa Ventures, Catherine was an investment banker for twenty years
and last served as Vice Chairman of Asia Investment Banking at JP Morgan where
she led with a focus on Greater China.  Under her leadership, JP Morgan was
named Best Investment Bank in Hong Kong for eight consecutive years.  She has
advised clients in marquee IPO’s, mergers and acquisitions, debt and derivative
transactions.  She was named Top 20 Women in Finance by Finance Asia in 2011.

Catherine worked as a management consultant at Oliver Wyman & Co in the U.S. and
London from 1990 and 1994.  She graduated from the Wharton School of the
University of Pennsylvania, summa cum laude, with majors in Finance and
Accounting.

Catherine is currently a member of the Penn Wharton Entrepreneurship Board and
member of the Wharton Asia Executive Board. She is also Vice Chair of the Penn
Asia Leadership Committee. She is a member of the Hong Kong Arts Development
Council Trust Fund. She also serves as Court Member and Business School Advisory
Council Member of HK University of Science and Technology where she was
recipient of the Honorary Fellowship Award in 2018. Catherine is also Chairman
of the Chamber of Hong Kong Listed Companies since Aug 2021.

<Program>

PAMELA FUNG

Managing Director,
Morgan Stanley
Investment Management
Private Equity Solutions
Pamela Fung is an Executive Director for Morgan Stanley Private Equity
Solutions, and leads PES’ Asian investment activities. She has 18 years of
industry experience. Prior to Morgan Stanley, Pamela was a consultant with
McKinsey's corporate finance practice in Hong Kong; she has also worked for
Monitor Group and Lehman Brothers. Pamela has a Law degree (first class honors)
from the University of Hong Kong and an M.B.A. with honors from the Wharton
School of the University of Pennsylvania.
<Program>

JONATHAN LARSEN

Chief Innovation Officer
Ping An Group;
Chairman and CEO,
Ping An Global Voyager Fund

Jonathan Larsen is now Chief Innovation Officer of Ping An Group and Chairman
and CEO of the Ping An Global Voyager Fund.

Jonathan spent 18 years at Citigroup where he was most recently Global Head of
the firm’s Retail Banking and Mortgage businesses, generating ~$12Bn in Revenues
and spanning 19 countries. He has been at the leading edge of the financial s
ervices industry for the last 3 3 years across the Asia Pacific region and
globally. He brings a unique blend of strategic vision, operational depth, and
understanding of the new technology landscape. He has led multiple large scale,
successful businesses across a wide range of markets and has extensive
experience in negotiating and managing partnerships and M&A transactions.

Prior to Citi, Jonathan was a Principal in the Financial Services Practice of
global management consulting firm, Booz Allen & Hamilton where he spent eight
years advising large banks and other financial institutions across Asia,
Australia and New Zealand and in the United States and Europe.

Jonathan is a Distinguished Fellow of the Institute of Banking and Finance,
Singapore and was named Retail Banker of the Year in 2011 by Asian Banker
magazine. He has been widely quoted in major business publications includi ng
the Financial Times, Bloomberg, Reuters, New York Times, Wall Street Journal,
the Economist as well as local media throughout Asia Pacific. Jonathan holds a
Bachelor of Arts (Hons) from the University of Melbourne.

<Program>

PHILEA CHIM

Senior Vice President,
QBN Capital

Philea leads our investments in UK and Europe, while also participates in our
activities in Asia.

Former Tech Policy Advisor in the UK Government. Philea is very familiar with
the tech ecosystem and investment landscape in UK and Europe, as well as
policies relating to Open Banking, Data Protection, and Digital Economy. Philea
is well connected in the tech sector, including with universities, VCs, and
public sector bodies, and is uniquely positioned to bridge between East and
West.

<Program>

EDITH YEUNG

General Partner,
Race Capital

Edith Yeung is a General Partner at Race Capital - an early-stage Silicon Valley
venture capital fund investing in all things infrastructure. Edith is the seed
investor in Solana (has been dubbed one of the best venture investments of all
time), Lightning Network, Agora.io, Placer.ai, RapidAPI, and 60 other amazing
startups.

Prior to Race Capital, Edith was a partner at 500 Startups, the world's most
active early-stage fund and incubator which invested in Twilio, Credit Karma,
Grab, and 2000 more companies.

Before 500, Edith was the general manager at Dolphin Browser, a Sequoia Capital
- backed mobile browser with over 150 million installs worldwide. Edith also
worked with many Fortune 500 companies such as Siebel, AMS, AT&T Wireless, and
Autodesk. She frequently speaks on venture capital, women in leadership, China
and Silicon Valley technology and investment landscape. She is also a frequent
guest lecturer at Berkeley and Stanford and commentator on BBC, CNBC, Wall
Street Journal, Bloomberg, SCMP, Techcrunch, The Information, etc.

<Program>

JANE WU

Chief Investment Officer, Springhill Fund

Jane Wu has over 14 years of asset management experience in public equity
market, mostly focusing on healthcare sector. Prior to launching Springhill, she
was a portfolio manager at Fidelity Management Research (FMR). In this role,
Jane was responsible for FMR's investments in the healthcare sector in Asia and
also had responsibilities for the healthcare sleeves for the Fidelity. In this
capacity, she followed healthcare companies in China, Japan, India, Korea and
ASEAN countries, covering businesses in pharmaceuticals, biotech, medical
device, and medical services industries. Prior to joining Fidelity in 2012, Jane
worked as an equity research analyst with CLSA, where she focused on China's
consumer sector and previously was an analyst at Credit Suisse.

Jane earned her Bachelor of Economics degree in economics and finance from
Tsinghua University and her Master of Business Administration degree in value
investing from Columbia University.

<Program>

TOMMY YIP

Managing Partner,
Unicorn Capital Partners
Tommy Yip is the Founding Partner of Unicorn Capital Partners, a tech-focused
venture capital platform specialized in primary fund investments, secondaries,
and direct investments in China. Prior to founding Unicorn, Tommy spend a decade
as Partner & Head of North Asia for Emerald Hill Capital Partners, an emerging
manager focused fund-of-funds in Asia. Before that, Tommy was Head of Research
at the AVCJ Group.
<Program>

CLEMENT TAM

Chief Executive Officer, ZERO Biotech

Clement has over 20 years of management experience with multinational
corporations across diverse industries.

Clement started his career with Jardine Matheson as group management trainee and
worked in multiple verticals. A serial entrepreneur, Clement started multiple
start-ups and successfully exited through M&As.

Clement leads RIT Biotech, a subsidiary of ZERO Biotech, to become the leading
downstream nuclear medicine player in Hong Kong. Clement joined RIT Biotech in
2018 and was appointed as the CEO of ZERO Biotech in 2020.

Clement received a master degree in Mechanical Engineering from Stanford
University.

<Program>

YUAN LIU,

Partner,
ZhenFund
Yuan Liu is a Partner at Zhenfund, a Beijing-based angel investment firm with 2
billion dollars under management and more than 1000 portfolio companies.  Yuan
joined the firm in 2014 and has since then led investments into more than 100
companies in various sectors, being mostly the first institutional investor. 
Notable investments include Momenta, CraiditX, Castbox, Amiro, Moti and
Monica.im.  Before joining Zhenfund, Yuan was a Senior Analyst at Greenspring
Associates, a venture capital investment firm in the U.S. where he led fund and
direct investments.  Yuan graduated from Washington and Lee University with a
Bachelor of Science in Accounting and Business Administration.
<Program>
 * Home
 * Past Events
 * Program
 * Register Now


© 2024 HKVCA. All rights reserved.